Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLACENTEX in Inactive Localized Scleroderma
NCT03388255Phase 4Terminated
- Sponsor
- Mastelli
- Start
- Nov 2016
- Primary completion
- Oct 2019
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of polideoxirybonucleotide in localized scleroderma, sponsored by Mastelli. Started Nov 2016; status: terminated.
02
Drugs
polideoxirybonucleotide
03
Conditions
localized scleroderma
Beyond the preview
Go deeper on NCT03388255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388255.